Synlogic Appoints Scott Plevy M.D. as Chief Scientific Officer

Synlogic to Webcast Presentation at the 18th Annual Needham Healthcare Conference

Synlogic to Webcast Presentation at the Oppenheimer 29th Annual Healthcare Conference

Synlogic Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update

Synlogic Announces Achievement of Milestone in Collaboration to Develop Synthetic Biotic™ Medicines to Treat Inflammatory Bowel Disease

Synlogic Announces Fourth Quarter and Full Year 2018 Conference Call and Webcast

Synlogic to Present at Investor Conferences in March

Synlogic to Webcast Presentation at the SVB Leerink 8th Annual Global Healthcare Conference

Synlogic Appoints Patricia N. Hurter, Ph.D. to Board of Directors

Science Translational Medicine Publishes First-in-Human Clinical Data and Supporting Preclinical Data for SYNB1020, Synlogic’s Synthetic Biotic™ Medicine in Development as a Potential Treatment for Hyperammonemia

Synlogic Progresses Clinical and Preclinical Pipeline and Outlines 2019 Catalysts

Synlogic Expands Capabilities in Manufacturing with the Appointment of Head of Technical Operations and Establishment of In-house Production of Clinical Trial Material for its Synthetic BioticTM Medicines